spacer
home > epc
PUBLICATIONS

European Pharmaceutical Contractor

 

European Pharmaceutical Contractor (EPC) is designed to fill a unique position in pharmaceutical publishing. Providing a dedicated platform of communication and information for the international pharmaceutical contract market, it consists of a series of articles and case studies written by eminent figures in contractor groups and traditional multinational pharmaceutical companies.

Each quarterly edition examines areas of importance – both economic and technical – to contract research organisations, contract manufacturers, regulatory controllers, consultants and analysts. This enables regulatory bodies to link directly with policy-makers both in major contractor groups and pharmaceutical companies, and thereby convey regulatory information directly from the governing bodies, but also ensure debate between the policy-makers and consultancy groups.

 

For further information please contact:

Advertising
Jonathan Smith

Editorial
Aimee-Rose O'Driscoll

We're also on Twitter! Follow us @EPCmagazine

Read our publications on the go in the Samedan app for iPhone and iPad. You can download issues for offline reading and our archives go as far back as 2008! Download for free on the App Store.


View the digital version of EPC




 

epc
 
 
Featured in this issue
The introduction
Editor’s Letter

With compliance deadlines looming, Graham Hughes reflects on the various regulatory updates featured in this issue.
Marketplace & Business
Outsourcing Models

The Perfect Match


Organisations often rush the preparatory stage when engaging with new suppliers, argues Tim Wright from Pillsbury Winthrop Shaw Pittman LLP. There is much to consider in selecting the right outsourcing model, as each comes with its own risks and benefits.
  Legal & Regulatory
Pharmacovigilance

Constant Change


Graeme Ladds
from PharSafer guides companies through the ever-evolving world of pharmacovigilance and considers what is to come in 2015. With key pieces of legislation to be resolved by July this year, there is plenty to keep businesses busy.

spacer
Edited by
Dr Graham Hughes,
Consultant in
Pharmaceutical
Development
Published quarterly in
March, June,
September and December

Banner of ESMO.EPC on Samedan
Banner of CIC.EPC on Samedan
 
Industry Events

Clinical Trial Supply New England

10-11 March 2015, Boston, USA

We are delighted to announce the Clinical Trial Supply New Englandconference will be taking place in Boston on the 10th and 11th March 2015. Building on the growing success of this conference, the 3rd annual event will once again provide a unique platform for discussion and debate into the biggest challenges currently facing the clinical supply chain.
More info >>

 
News and Press Releases

How to Achieve High Speed High Resolution Glycan Mapping for MAb Characterization

To help researchers overcome the challenges associated with glycan analysis, Agilent has introduced its AdvanceBio Glycan Mapping columns which have been engineered and manufactured to deliver rapid, reproducible, high-resolution glycan identification to increase throughput without sacrificing the quality of data.
More info >>

air transport logo

 

White Papers

Clinical Trials in Russia Orange Paper: 2nd Quarter 2014

Synergy Research Group

The Ministry of Health of Russian Federation approved 194 new clinical trials of all types including local and bioequivalence studies during the 2nd Quarter of 2014 (3% less than at the same period of the last year). The main contribution to the total number of studies was made by multinational multi-center clinical trials (MMCT) and the number of these studies stayed the same as in Q2 2013 – 81 studies. The number of bioequivalence studies (BE) decreased from 76 studies in Q2 2013 to 59 in Q2 2014, a 22% decrease from last year’s figure. The number of local clinical trials (LCT) increased from 42 in Q2 2013 to 54 clinical trials in Q2 2014.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement